We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
-5.54%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.86%
AUM
$1.58B
AUM Growth
+$92.6M
Cap. Flow
+$199M
Cap. Flow %
12.58%
Top 10 Hldgs %
29.03%
Holding
140
New
2
Increased
50
Reduced
52
Closed
5

Top Buys

Rank Stock Value
1
DORM icon
Dorman Products
DORM
+$21.5M
2
RAVN
Raven Industries Inc
RAVN
+$16.8M
3
HSTM icon
HealthStream
HSTM
+$16.5M
4
CMD
Cantel Medical Corporation
CMD
+$14.6M
5
SPSC icon
SPS Commerce
SPSC
+$13.3M

Top Sells

Rank Stock Value
1
ACCL
Accelrys Inc
ACCL
+$20.3M
2
CSGP icon
CoStar Group
CSGP
+$16.9M
3
FDS icon
Factset
FDS
+$14.3M
4
AVAV icon
AeroVironment
AVAV
+$13.6M
5
VIVO
Meridian Bioscience Inc
VIVO
+$5.98M

Sector Composition

Rank Sector Weight
1 Technology 24.23%
2 Healthcare 16.21%
3 Industrials 15.07%
4 Materials 8.3%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBA
126
DELISTED
Walgreens Boots Alliance
WBA
$202K 0.01%
3,065
-750
-20% -$47.1K
AMGN icon
127
Amgen
AMGN
$220B
$201K 0.01%
+1,630
New +$198K
CAB
128
DELISTED
Cabela's Inc
CAB
$201K 0.01%
3,070
-1,260
-29% -$84.8K
STRM
129
DELISTED
Streamline Health Solutions
STRM
$162K 0.01%
2,153
– –
GKNT
130
DELISTED
GEEKNET INC COM NEW
GKNT
$152K 0.01%
10,850
+50
+0.5% +$817
HNSN
131
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$75K ﹤0.01%
2,880
– –
MDW
132
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
$28K ﹤0.01%
26,600
– –
XRSC
133
DELISTED
XRS CORP COM STK (MN)
XRSC
$27K ﹤0.01%
10,000
– –
ETRM
134
DELISTED
EnteroMedics Inc.
ETRM
$18K ﹤0.01%
10
– –
LUNA
135
DELISTED
Luna Innovations Incorporated
LUNA
$15K ﹤0.01%
10,000
– –
CHRW icon
136
C.H. Robinson
CHRW
$17.1B
– –
-5,775
Closed -$337K
DD icon
137
DuPont de Nemours
DD
$19.5B
– –
-2,211
Closed -$249K
URBN icon
138
Urban Outfitters
URBN
$6.48B
– –
-5,980
Closed -$222K
FRX
139
DELISTED
FOREST LABORATORIES INC
FRX
– –
-6,470
Closed -$388K
ACCL
140
DELISTED
Accelrys Inc
ACCL
– –
-2,122,788
Closed -$20.3M
2 3 4 5
6

Similar funds

SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $4.53B AUM 21.1% 1-Year Est. Return

Conestoga Capital Advisors's Q1 2014 Portfolio in Review

As of Q1 2014, Conestoga Capital Advisors held 140 positions worth $1.58B, up 6.2% from $1.49B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Conestoga Capital Advisors deployed $199M of net new capital in Q1 2014, opening 2 new positions and adding to 50 existing holdings. Its largest new stake was Cantel Medical Corporation: 444,000 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was CoStar Group, an estimated $16.9M trimmed.

  • Conestoga Capital Advisors's largest Q1 2014 buy was Cantel Medical Corporation: 444,000 shares worth $15M.
  • Conestoga Capital Advisors added most to Dorman Products in Q1 2014, an estimated $21.5M increase.
  • Conestoga Capital Advisors's biggest Q1 2014 reduction was CoStar Group, cutting an estimated $16.9M.
  • Conestoga Capital Advisors fully exited Accelrys Inc in Q1 2014, selling an estimated $20.3M.
  • Conestoga Capital Advisors's ten largest holdings make up 29% of its $1.58B portfolio in Q1 2014.
  • Conestoga Capital Advisors opened 2 new positions and closed 5 in Q1 2014.
  • Conestoga Capital Advisors's portfolio value rose 6.2% quarter-over-quarter to $1.58B.

Based on Conestoga Capital Advisors's 13F filing for Q1 2014, filed 23 Apr 2014.